Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
belgian startups
biotech ipos
boston
boston blog main
boston top stories
clinical trials
dyne therapeutics
fda
features
free
genetics
globachem
life sciences
metacrine
myotonic dystrophy type 1
national blog main
nonalcoholic steatohepatitis
precision agriculture
precision medicine
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
ulcerative colitis
What
company
developing
2
×
genetic
2
×
million
2
×
raised
agriculture
analysis
applications
belgian
biostrand
biotechnology
brings
comes
continue
crop
data
disorders
disrupt
drug
dyne
dyne’s
founded
fund
globachem
identifies
investment
ipo
koen
lauded
medicine
medicines
methodology
muscle
muscular
paesmans
potential
precision
preclinical
protection
quaghebeur
Language
unset
2
×
Current search:
million
×
developing
×
unset
×
genetic
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@tech.eu
3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
